Cargando…
Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal forms of cancer and is known to have low immunogenicity and an immunosuppressive microenvironment. It is also characterized by high accumulation of dense stroma, composed of mostly cancer-associated fibroblasts (CAFs). Mul...
Autores principales: | Schoonderwoerd, Mark J A, Hakuno, Sarah K, Sassen, Martijn, Kuhlemaijer, Eleonore B, Paauwe, Madelon, Slingerland, Marije, Fransen, Marieke F, Hawinkels, Lukas J A C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565992/ https://www.ncbi.nlm.nih.gov/pubmed/34744438 http://dx.doi.org/10.2147/OTT.S322276 |
Ejemplares similares
-
Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
por: Hakuno, Sarah K., et al.
Publicado: (2022) -
Endoglin Targeting: Lessons Learned and Questions That Remain
por: Liu, Yingmiao, et al.
Publicado: (2020) -
Endoglin: Beyond the Endothelium
por: Schoonderwoerd, Mark J. A., et al.
Publicado: (2020) -
Endoglin and squamous cell carcinomas
por: Hakuno, Sarah K., et al.
Publicado: (2023) -
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness
por: Momoi, Yusaku, et al.
Publicado: (2021)